(Q33749017)

29 July 2017

1 reference

title

Facing up to the diagnostic uncertainty and management of onychomycoses (English)

1 reference

29 July 2017

Arrese JE

1

1 reference

PubMed ID

10515522

29 July 2017

Piérard-Franchimont C

series ordinal

2

1 reference

PubMed ID

10515522

29 July 2017

Piérard GE

series ordinal

3

1 reference

29 July 2017

1 September 1999

1 reference

International Journal of Dermatology

29 July 2017

1 reference

29 July 2017

38 Suppl 2

1 reference

29 July 2017

1-6

1 reference

The epidemiology of onychomycosis in Britain.

29 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00007.X

Onychomycosis: a significant medical disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00007.X

Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists' offices in Ontario, Canada--a multicenter survey of 2001 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00007.X

Present and potential diagnostic techniques in onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00007.X

Causative pathogens in onychomycosis and the possibility of treatment resistance: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00007.X

Onychomycosis: making sense of the assessment of anti-fungal drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00007.X

Evolving role of nondermatophytes in onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00007.X

Fatal hyalohyphomycosis following Fusarium onychomycosis in an immunocompromised patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00007.X

Onychomycosis and keratomycosis caused by Alternaria sp. A bipolar opportunistic infection in a wood-pulp worker on chronic steroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00007.X

Treatment of onychomycosis: traditional approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00007.X

New approaches to the treatment of onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00007.X

Antifungal agents: an overview. Part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00007.X

New therapies for onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00007.X

Treatment and prophylaxis of tinea infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00007.X

Antifungal activity of itraconazole and terbinafine in human stratum corneum: a comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00007.X

Itraconazole penetrates the nail via the nail matrix and the nail bed--an investigation in onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00007.X

Animal models for testing topical corticosteroid potency: a review and some suggested new approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00007.X

Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Seventh Lamisil German Onychomycosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00007.X

Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00007.X

21 January 2018

Terbinafine: an update

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00007.X

Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00007.X

Itraconazole in onychomycosis: intermittent dose schedule.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00007.X

Itraconazole pulse therapy for onychomycosis and dermatomycoses: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00007.X

A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00007.X

Itraconazole for the treatment of onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00007.X

Onychomycosis: successful treatment with once-weekly fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00007.X

Fluconazole in the treatment of severe onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00007.X

Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails. A US analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00007.X

Candida onychomycosis--an evaluation of the role of Candida species in nail disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00007.X

Terbinafine in onychomycosis with involvement by non-dermatophytic fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00007.X

Treatment of Candida nail infection with terbinafine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00007.X

Itraconazole therapy is effective for pedal onychomycosis caused by some nondermatophyte molds and in mixed infection with dermatophytes and molds: A multicenter study with 36 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00007.X

10.1046/J.1365-4362.1999.00007.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10515522